Business Description
Bullfrog AI Holdings is a US-based company that uses artificial intelligence to discover and develop new medicines. Its proprietary platform, bfLEAP, processes complex medical data to help drug developers make faster, better-informed decisions. The company is advancing several of its own drug candidates targeting brain cancer, obesity, and liver disease, supported by licensing agreements with George Washington University and Johns Hopkins University. Founded in 2017 and based in Gaithersburg, Maryland, Bullfrog AI also partners with the Lieber Institute for Brain Development to pursue precision treatments for disorders of the central nervous system.
